SYED ALI: Open Payments
NPI 1417148644 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 22 payments from 6 companies in 2025. Trend: 2023 $529 · 2024 $520 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $125 |
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Lundbeck LLC | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Alkermes, Inc. | 1 | $18 |
Products named: VRAYLAR, UZEDY, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, SPRAVATO, ARISTADA, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
